Conditions: Healthy Volunteers
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 30
Healthy volunteers: yes

Brief summary:
The main purpose of this study is to find out how the body will react to a study drug called baricitinib when taken with another drug called omeprazole.

For each participant, this study will include 2 periods in fixed order. The study will last approximately 25 days, not including screening.

Detailed description:

Arms:
arm 1: Baricitinib - 10 milligram (mg) tablet administered orally, once, on Day 1. arm 2: Baricitinib - 10 mg tablet administered orally, once, on Day 10. Omeprazole - 40 mg capsule administered orally once daily (QD) for 8 days (Days 3 through 10).

Interventions: intervention 1: Baricitinib intervention 2: Omeprazole
Intervention descriptions: intervention 1: Administered orally intervention 2: Administered orally

Protocol document: